Global 3D Bioprinting Market By Offering (Hardware – Bioprinters, Bioinks, Solutions); By Technology (Extrusion based, Laser based, Press-assisted, Stereolithography, Light based, Others); By Application (Tissue Engineering, Transplantable organs, Drug development/ screening, toxicology screening, tissue model for cancer research and others); By End Users (Pharmaceutical Companies, Research & Academic Institutions, Medical Device Manufacturers, Contract Research Organization); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
3D bioprinting happens to be a technology that works by using bioinks that is mixed with living cells, and then are printed in 3D in an attempt to build structures that have three dimensions and are just like the natural tissue. At present, this technology is being used extensively in various industries, like tissue engineering and the development of the new drug. 3D bioprinting has been in this world since years and has been rapidly evolving courtesy of rampant research activities across various countries. It was the year 1984, when a guy named Charles Hull made a breakthrough invention in the field of 3D printing by filing a patent for the commercial 3D printing technology claiming it as the first of such nature. And since then it has been said that the 3D printing was born, and it led to the creation of the base for 3D bioprinting as well. Bioprinting technology arrived into picture in the year 1988, courtesy of Robert J. Klebe who used inkjet printer for the purpose of printing cells. Following this, the bioprinting has continuously changed and made progress, and led to the discovery of new methods and techniques. Today, 3D bioprinting is extremely helpful for various activities and being used extensively, and this has been contributing to the growth of the global 3D bioprinting market.
With the help of technology and bioprinted structures, researchers can be successfully studying functions of the human body in vitro. 3D bioprinted structures happen to be more biologically relevant as compared to studies performed in vitro in 2D. Most of the times, 3D bioprinting is brought in the use for numerous biological applications when it is regards with the tissue engineering, bioengineering and materials science. This technology is also extensively used for the purpose of pharmaceutical development and validation of the drug. There are numerous benefits of 3D bioprinting technology like it grants permission of mimicking the real structure of desired tissue/organ etc. It is likely to revolutionize the future of the medical treatment and create treatments that happen to be patient-specific and organ-specific in nature. By using 3D bioprinting technology, one can gauge or examine the effects of drugs in more accurate manner. All these factors help the global 3D bioprinting market grow.
In terms of revenue, global 3D bioprinting market was valued at US$ 1.2 Bn in 2021 growing at a CAGR of 22% over the forecast period (2022 – 2030). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global 3D Bioprinting Market Revenue & Forecast, (US$ Million), 2015 – 2030
Offering Outlook
Based on the offering outlook, the global 3D bioprinting market has been segmented into hardware and solutions. The hardware segment that accounts for majority of revenue generated by this market has been further bifurcated into bioprinters and bioinks. Bioinks is primarily used as the base material at the time of the bioprinting body structures with bioprinters. 3D bioinks happen to laden with cells, free of scaffold and free of cells, which is a bioink that is hydrol-gel based and can customized as it is created with the help of nanofibrillar cellulose and water.
Region Outlook
Based on region, the continent of the North America has been generating most of the money for the global 3D bioprinting market in the year 2021. The countries like the United States and Canada have witnessed massive technological advancement over the period of last few. The healthcare sector is also growing aggressively owing to the technological advancement, and this is why the market is growing at a rampant rate.
Competitive Landscape
The report provides both, qualitative and quantitative research of global 3D bioprinting market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global 3D bioprinting market are:
- 3D Systems, Inc.
- Advanced Solutions Life Sciences, LLC
- Allevi, Inc
- Aspect Biosystems Ltd
- Brinter
- Cellbricks
- CELLLINK
- CYFUSE BIOMEDICAL K.K.
- FELIXprinter
- Fluicell AB
- GeSim – Gesellschaft fur Silizium-Mikrosysteme mbH
- Medprin
- nScrypt
- Organovo Holdings Inc
- regenHU
- Other Industry Participants
Global 3D Bioprinting Market:
By Offering
- Hardware
- Bioprinters
- Bioinks
- Solutions
By Technology
- Extrusion based
- Ink-jet
- Laser based
- Press-assisted
- Stereolithography
- Light based
- Others
By Application
- Tissue engineering
- Transplantable organs
- Drug development/ screening
- Toxicology Screening
- Tissue model for cancer research
- Others
By End Users
- Pharmaceutical Companies
- Research & Academic Institutions
- Medical Device Manufacturers
- Contract Research Organization
By Region
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Table of Contents
Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2020
1.2.2. Base
Year: 2021
1.2.3. Forecast
Years: 2022 - 2030
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of 3D Bioprinting Market
6. Market Synopsis: 3D
Bioprinting Market
7. 3D Bioprinting Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in
3D Bioprinting Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: 3D Bioprinting Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on 3D Bioprinting Market
8. Global 3D Bioprinting Market Analysis and Forecasts, 2022 -
2030
8.1. Overview
8.1.1. Global
3D Bioprinting Market Revenue (US$ Mn)
8.2. Global 3D
Bioprinting Market Revenue (US$ Mn) and Forecasts, By Offering
8.2.1. Hardware (Definition, Market Estimation and
Penetration, 2015 - 2021, Market Estimation (2015 - 2021), Market Forecast (2022
- 2030), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Bioprinters, Bioinks )
8.2.1.1. Bioprinters
8.2.1.2. Bioinks
8.2.2. Solutions
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2021
8.2.2.3. Market Forecast, 2022 - 2030
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2021
8.2.2.5.1.2. Market
Forecast, 2022 - 2030
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2021
8.2.2.5.2.2. Market
Forecast, 2022 - 2030
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2021
8.2.2.5.3.2. Market
Forecast, 2022 - 2030
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2021
8.2.2.5.4.2. Market
Forecast, 2022 - 2030
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2021
8.2.2.5.5.2. Market
Forecast, 2022 - 2030
8.3. Key
Segment for Channeling Investments
8.3.1. By
Offering
9. Global 3D Bioprinting Market Analysis and Forecasts, 2022 -
2030
9.1. Overview
9.2. Global 3D
Bioprinting Market Revenue (US$ Mn) and Forecasts, By Technology
9.2.1. Extrusion
based
9.2.1.1. Definition
9.2.1.2. Market Estimation and Penetration, 2015 - 2021
9.2.1.3. Market Forecast, 2022 - 2030
9.2.1.4. Compound Annual Growth Rate (CAGR)
9.2.1.5. Regional Bifurcation
9.2.1.5.1. North America
9.2.1.5.1.1. Market
Estimation, 2015 - 2021
9.2.1.5.1.2. Market
Forecast, 2022 - 2030
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 - 2021
9.2.1.5.2.2. Market
Forecast, 2022 - 2030
9.2.1.5.3. Asia Pacific
9.2.1.5.3.1. Market
Estimation, 2015 - 2021
9.2.1.5.3.2. Market
Forecast, 2022 - 2030
9.2.1.5.4. Middle East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 - 2021
9.2.1.5.4.2. Market
Forecast, 2022 - 2030
9.2.1.5.5. Latin America
9.2.1.5.5.1. Market
Estimation, 2015 - 2021
9.2.1.5.5.2. Market
Forecast, 2022 - 2030
9.2.2. Ink-jet
9.2.2.1. Definition
9.2.2.2. Market Estimation and Penetration, 2015 - 2021
9.2.2.3. Market Forecast, 2022 - 2030
9.2.2.4. Compound Annual Growth Rate (CAGR)
9.2.2.5. Regional Bifurcation
9.2.2.5.1. North America
9.2.2.5.1.1. Market
Estimation, 2015 - 2021
9.2.2.5.1.2. Market
Forecast, 2022 - 2030
9.2.2.5.2. Europe
9.2.2.5.2.1. Market
Estimation, 2015 - 2021
9.2.2.5.2.2. Market
Forecast, 2022 - 2030
9.2.2.5.3. Asia Pacific
9.2.2.5.3.1. Market
Estimation, 2015 - 2021
9.2.2.5.3.2. Market
Forecast, 2022 - 2030
9.2.2.5.4. Middle East and Africa
9.2.2.5.4.1. Market
Estimation, 2015 - 2021
9.2.2.5.4.2. Market
Forecast, 2022 - 2030
9.2.2.5.5. Latin America
9.2.2.5.5.1. Market
Estimation, 2015 - 2021
9.2.2.5.5.2. Market
Forecast, 2022 - 2030
9.2.3. Laser
based
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2021
9.2.3.3. Market Forecast, 2022 - 2030
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2021
9.2.3.5.1.2. Market
Forecast, 2022 - 2030
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2021
9.2.3.5.2.2. Market
Forecast, 2022 - 2030
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2021
9.2.3.5.3.2. Market
Forecast, 2022 - 2030
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2021
9.2.3.5.4.2. Market
Forecast, 2022 - 2030
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2021
9.2.3.5.5.2. Market
Forecast, 2022 - 2030
9.2.4. Press-assisted
9.2.4.1. Definition
9.2.4.2. Market Estimation and Penetration, 2015 - 2021
9.2.4.3. Market Forecast, 2022 - 2030
9.2.4.4. Compound Annual Growth Rate (CAGR)
9.2.4.5. Regional Bifurcation
9.2.4.5.1. North America
9.2.4.5.1.1. Market
Estimation, 2015 - 2021
9.2.4.5.1.2. Market
Forecast, 2022 - 2030
9.2.4.5.2. Europe
9.2.4.5.2.1. Market
Estimation, 2015 - 2021
9.2.4.5.2.2. Market
Forecast, 2022 - 2030
9.2.4.5.3. Asia Pacific
9.2.4.5.3.1. Market
Estimation, 2015 - 2021
9.2.4.5.3.2. Market
Forecast, 2022 - 2030
9.2.4.5.4. Middle East and Africa
9.2.4.5.4.1. Market
Estimation, 2015 - 2021
9.2.4.5.4.2. Market
Forecast, 2022 - 2030
9.2.4.5.5. Latin America
9.2.4.5.5.1. Market
Estimation, 2015 - 2021
9.2.4.5.5.2. Market
Forecast, 2022 - 2030
9.2.5. Stereolithography
9.2.5.1. Definition
9.2.5.2. Market Estimation and Penetration, 2015 - 2021
9.2.5.3. Market Forecast, 2022 - 2030
9.2.5.4. Compound Annual Growth Rate (CAGR)
9.2.5.5. Regional Bifurcation
9.2.5.5.1. North America
9.2.5.5.1.1. Market
Estimation, 2015 - 2021
9.2.5.5.1.2. Market
Forecast, 2022 - 2030
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 - 2021
9.2.5.5.2.2. Market
Forecast, 2022 - 2030
9.2.5.5.3. Asia Pacific
9.2.5.5.3.1. Market
Estimation, 2015 - 2021
9.2.5.5.3.2. Market
Forecast, 2022 - 2030
9.2.5.5.4. Middle East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 - 2021
9.2.5.5.4.2. Market
Forecast, 2022 - 2030
9.2.5.5.5. Latin America
9.2.5.5.5.1. Market
Estimation, 2015 - 2021
9.2.5.5.5.2. Market
Forecast, 2022 - 2030
9.2.6. Light
based
9.2.6.1. Definition
9.2.6.2. Market Estimation and Penetration, 2015 - 2021
9.2.6.3. Market Forecast, 2022 - 2030
9.2.6.4. Compound Annual Growth Rate (CAGR)
9.2.6.5. Regional Bifurcation
9.2.6.5.1. North America
9.2.6.5.1.1. Market
Estimation, 2015 - 2021
9.2.6.5.1.2. Market
Forecast, 2022 - 2030
9.2.6.5.2. Europe
9.2.6.5.2.1. Market
Estimation, 2015 - 2021
9.2.6.5.2.2. Market
Forecast, 2022 - 2030
9.2.6.5.3. Asia Pacific
9.2.6.5.3.1. Market
Estimation, 2015 - 2021
9.2.6.5.3.2. Market
Forecast, 2022 - 2030
9.2.6.5.4. Middle East and Africa
9.2.6.5.4.1. Market
Estimation, 2015 - 2021
9.2.6.5.4.2. Market
Forecast, 2022 - 2030
9.2.6.5.5. Latin America
9.2.6.5.5.1. Market
Estimation, 2015 - 2021
9.2.6.5.5.2. Market
Forecast, 2022 - 2030
9.2.7. Others
9.2.7.1. Definition
9.2.7.2. Market Estimation and Penetration, 2015 - 2021
9.2.7.3. Market Forecast, 2022 - 2030
9.2.7.4. Compound Annual Growth Rate (CAGR)
9.2.7.5. Regional Bifurcation
9.2.7.5.1. North America
9.2.7.5.1.1. Market
Estimation, 2015 - 2021
9.2.7.5.1.2. Market
Forecast, 2022 - 2030
9.2.7.5.2. Europe
9.2.7.5.2.1. Market
Estimation, 2015 - 2021
9.2.7.5.2.2. Market
Forecast, 2022 - 2030
9.2.7.5.3. Asia Pacific
9.2.7.5.3.1. Market
Estimation, 2015 - 2021
9.2.7.5.3.2. Market
Forecast, 2022 - 2030
9.2.7.5.4. Middle East and Africa
9.2.7.5.4.1. Market
Estimation, 2015 - 2021
9.2.7.5.4.2. Market
Forecast, 2022 - 2030
9.2.7.5.5. Latin America
9.2.7.5.5.1. Market
Estimation, 2015 - 2021
9.2.7.5.5.2. Market
Forecast, 2022 - 2030
9.3. Key
Segment for Channeling Investments
9.3.1. By
Technology
10. Global 3D Bioprinting Market Analysis and Forecasts, 2022 -
2030
10.1. Overview
10.2. Global 3D
Bioprinting Market Revenue (US$ Mn) and Forecasts, By Application
10.2.1. Tissue
engineering
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2021
10.2.1.3. Market Forecast, 2022 - 2030
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2021
10.2.1.5.1.2. Market
Forecast, 2022 - 2030
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2021
10.2.1.5.2.2. Market
Forecast, 2022 - 2030
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2021
10.2.1.5.3.2. Market
Forecast, 2022 - 2030
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2021
10.2.1.5.4.2. Market
Forecast, 2022 - 2030
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2021
10.2.1.5.5.2. Market
Forecast, 2022 - 2030
10.2.2. Transplantable
organs
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2021
10.2.2.3. Market Forecast, 2022 - 2030
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2021
10.2.2.5.1.2. Market
Forecast, 2022 - 2030
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2021
10.2.2.5.2.2. Market
Forecast, 2022 - 2030
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2021
10.2.2.5.3.2. Market
Forecast, 2022 - 2030
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2021
10.2.2.5.4.2. Market
Forecast, 2022 - 2030
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2021
10.2.2.5.5.2. Market
Forecast, 2022 - 2030
10.2.3. Drug
development/screening
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2021
10.2.3.3. Market Forecast, 2022 - 2030
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 - 2021
10.2.3.5.1.2. Market
Forecast, 2022 - 2030
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2021
10.2.3.5.2.2. Market
Forecast, 2022 - 2030
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2021
10.2.3.5.3.2. Market
Forecast, 2022 - 2030
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2021
10.2.3.5.4.2. Market
Forecast, 2022 - 2030
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 - 2021
10.2.3.5.5.2. Market
Forecast, 2022 - 2030
10.2.4. Toxicology
Screening
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 - 2021
10.2.4.3. Market Forecast, 2022 - 2030
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market
Estimation, 2015 - 2021
10.2.4.5.1.2. Market
Forecast, 2022 - 2030
10.2.4.5.2. Europe
10.2.4.5.2.1. Market
Estimation, 2015 - 2021
10.2.4.5.2.2. Market
Forecast, 2022 - 2030
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market
Estimation, 2015 - 2021
10.2.4.5.3.2. Market
Forecast, 2022 - 2030
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market
Estimation, 2015 - 2021
10.2.4.5.4.2. Market
Forecast, 2022 - 2030
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market
Estimation, 2015 - 2021
10.2.4.5.5.2. Market
Forecast, 2022 - 2030
10.2.5. Tissue
model for cancer research
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2015 - 2021
10.2.5.3. Market Forecast, 2022 - 2030
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market
Estimation, 2015 - 2021
10.2.5.5.1.2. Market
Forecast, 2022 - 2030
10.2.5.5.2. Europe
10.2.5.5.2.1. Market
Estimation, 2015 - 2021
10.2.5.5.2.2. Market
Forecast, 2022 - 2030
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market
Estimation, 2015 - 2021
10.2.5.5.3.2. Market
Forecast, 2022 - 2030
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market
Estimation, 2015 - 2021
10.2.5.5.4.2. Market
Forecast, 2022 - 2030
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market
Estimation, 2015 - 2021
10.2.5.5.5.2. Market
Forecast, 2022 - 2030
10.2.6. Others
10.2.6.1. Definition
10.2.6.2. Market Estimation and Penetration, 2015 - 2021
10.2.6.3. Market Forecast, 2022 - 2030
10.2.6.4. Compound Annual Growth Rate (CAGR)
10.2.6.5. Regional Bifurcation
10.2.6.5.1. North America
10.2.6.5.1.1. Market
Estimation, 2015 - 2021
10.2.6.5.1.2. Market
Forecast, 2022 - 2030
10.2.6.5.2. Europe
10.2.6.5.2.1. Market
Estimation, 2015 - 2021
10.2.6.5.2.2. Market
Forecast, 2022 - 2030
10.2.6.5.3. Asia Pacific
10.2.6.5.3.1. Market
Estimation, 2015 - 2021
10.2.6.5.3.2. Market
Forecast, 2022 - 2030
10.2.6.5.4. Middle East and Africa
10.2.6.5.4.1. Market
Estimation, 2015 - 2021
10.2.6.5.4.2. Market
Forecast, 2022 - 2030
10.2.6.5.5. Latin America
10.2.6.5.5.1. Market
Estimation, 2015 - 2021
10.2.6.5.5.2. Market
Forecast, 2022 - 2030
10.3. Key
Segment for Channeling Investments
10.3.1. By
Application
11. Global 3D Bioprinting Market Analysis and Forecasts, 2022 -
2030
11.1. Overview
11.2. Global 3D
Bioprinting Market Revenue (US$ Mn) and Forecasts, By End Users
11.2.1. Pharmaceutical
Companies
11.2.1.1. Definition
11.2.1.2. Market Estimation and Penetration, 2015 - 2021
11.2.1.3. Market Forecast, 2022 - 2030
11.2.1.4. Compound Annual Growth Rate (CAGR)
11.2.1.5. Regional Bifurcation
11.2.1.5.1. North America
11.2.1.5.1.1. Market
Estimation, 2015 - 2021
11.2.1.5.1.2. Market
Forecast, 2022 - 2030
11.2.1.5.2. Europe
11.2.1.5.2.1. Market
Estimation, 2015 - 2021
11.2.1.5.2.2. Market
Forecast, 2022 - 2030
11.2.1.5.3. Asia Pacific
11.2.1.5.3.1. Market
Estimation, 2015 - 2021
11.2.1.5.3.2. Market
Forecast, 2022 - 2030
11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1. Market
Estimation, 2015 - 2021
11.2.1.5.4.2. Market
Forecast, 2022 - 2030
11.2.1.5.5. Latin America
11.2.1.5.5.1. Market
Estimation, 2015 - 2021
11.2.1.5.5.2. Market
Forecast, 2022 - 2030
11.2.2. Research
and Academic Institutions
11.2.2.1. Definition
11.2.2.2. Market Estimation and Penetration, 2015 - 2021
11.2.2.3. Market Forecast, 2022 - 2030
11.2.2.4. Compound Annual Growth Rate (CAGR)
11.2.2.5. Regional Bifurcation
11.2.2.5.1. North America
11.2.2.5.1.1. Market
Estimation, 2015 - 2021
11.2.2.5.1.2. Market
Forecast, 2022 - 2030
11.2.2.5.2. Europe
11.2.2.5.2.1. Market
Estimation, 2015 - 2021
11.2.2.5.2.2. Market
Forecast, 2022 - 2030
11.2.2.5.3. Asia Pacific
11.2.2.5.3.1. Market
Estimation, 2015 - 2021
11.2.2.5.3.2. Market
Forecast, 2022 - 2030
11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1. Market
Estimation, 2015 - 2021
11.2.2.5.4.2. Market
Forecast, 2022 - 2030
11.2.2.5.5. Latin America
11.2.2.5.5.1. Market
Estimation, 2015 - 2021
11.2.2.5.5.2. Market
Forecast, 2022 - 2030
11.2.3. Medical
Device Manufacturers
11.2.3.1. Definition
11.2.3.2. Market Estimation and Penetration, 2015 - 2021
11.2.3.3. Market Forecast, 2022 - 2030
11.2.3.4. Compound Annual Growth Rate (CAGR)
11.2.3.5. Regional Bifurcation
11.2.3.5.1. North America
11.2.3.5.1.1. Market
Estimation, 2015 - 2021
11.2.3.5.1.2. Market
Forecast, 2022 - 2030
11.2.3.5.2. Europe
11.2.3.5.2.1. Market
Estimation, 2015 - 2021
11.2.3.5.2.2. Market
Forecast, 2022 - 2030
11.2.3.5.3. Asia Pacific
11.2.3.5.3.1. Market
Estimation, 2015 - 2021
11.2.3.5.3.2. Market
Forecast, 2022 - 2030
11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1. Market
Estimation, 2015 - 2021
11.2.3.5.4.2. Market
Forecast, 2022 - 2030
11.2.3.5.5. Latin America
11.2.3.5.5.1. Market
Estimation, 2015 - 2021
11.2.3.5.5.2. Market
Forecast, 2022 - 2030
11.2.4. Contract
Research Organization
11.2.4.1. Definition
11.2.4.2. Market Estimation and Penetration, 2015 - 2021
11.2.4.3. Market Forecast, 2022 - 2030
11.2.4.4. Compound Annual Growth Rate (CAGR)
11.2.4.5. Regional Bifurcation
11.2.4.5.1. North America
11.2.4.5.1.1. Market
Estimation, 2015 - 2021
11.2.4.5.1.2. Market
Forecast, 2022 - 2030
11.2.4.5.2. Europe
11.2.4.5.2.1. Market
Estimation, 2015 - 2021
11.2.4.5.2.2. Market
Forecast, 2022 - 2030
11.2.4.5.3. Asia Pacific
11.2.4.5.3.1. Market
Estimation, 2015 - 2021
11.2.4.5.3.2. Market
Forecast, 2022 - 2030
11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1. Market
Estimation, 2015 - 2021
11.2.4.5.4.2. Market
Forecast, 2022 - 2030
11.2.4.5.5. Latin America
11.2.4.5.5.1. Market
Estimation, 2015 - 2021
11.2.4.5.5.2. Market
Forecast, 2022 - 2030
11.3. Key
Segment for Channeling Investments
11.3.1. By End Users
12. North America 3D Bioprinting Market Analysis and Forecasts, 2022
- 2030
12.1. Overview
12.1.1. North
America 3D Bioprinting Market Revenue (US$ Mn)
12.2. North
America 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By Offering
12.2.1. Hardware
12.2.1.1. Bioprinters
12.2.1.2. Bioinks
12.2.2. Solutions
12.3. North
America 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By Technology
12.3.1. Extrusion
based
12.3.2. Ink-jet
12.3.3. Laser
based
12.3.4. Press-assisted
12.3.5. Stereolithography
12.3.6. Light
based
12.3.7. Others
12.4. North
America 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By Application
12.4.1. Tissue
engineering
12.4.2. Transplantable
organs
12.4.3. Drug
development/screening
12.4.4. Toxicology
Screening
12.4.5. Tissue
model for cancer research
12.4.6. Others
12.5. North
America 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By End Users
12.5.1. Pharmaceutical
Companies
12.5.2. Research
and Academic Institutions
12.5.3. Medical
Device Manufacturers
12.5.4. Contract
Research Organization
12.6. North
America 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1. U.S 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Offering
12.6.1.1.1. Hardware
12.6.1.1.1.1. Bioprinters
12.6.1.1.1.2. Bioinks
12.6.1.1.2. Solutions
12.6.1.2. U.S 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Technology
12.6.1.2.1. Extrusion based
12.6.1.2.2. Ink-jet
12.6.1.2.3. Laser based
12.6.1.2.4. Press-assisted
12.6.1.2.5. Stereolithography
12.6.1.2.6. Light based
12.6.1.2.7. Others
12.6.1.3. U.S 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Application
12.6.1.3.1. Tissue engineering
12.6.1.3.2. Transplantable organs
12.6.1.3.3. Drug development/screening
12.6.1.3.4. Toxicology Screening
12.6.1.3.5. Tissue model for cancer research
12.6.1.3.6. Others
12.6.1.4. U.S 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By End Users
12.6.1.4.1. Pharmaceutical Companies
12.6.1.4.2. Research and Academic Institutions
12.6.1.4.3. Medical Device Manufacturers
12.6.1.4.4. Contract Research Organization
12.6.2. Canada
12.6.2.1. Canada 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Offering
12.6.2.1.1. Hardware
12.6.2.1.1.1. Bioprinters
12.6.2.1.1.2. Bioinks
12.6.2.1.2. Solutions
12.6.2.2. Canada 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Technology
12.6.2.2.1. Extrusion based
12.6.2.2.2. Ink-jet
12.6.2.2.3. Laser based
12.6.2.2.4. Press-assisted
12.6.2.2.5. Stereolithography
12.6.2.2.6. Light based
12.6.2.2.7. Others
12.6.2.3. Canada 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Application
12.6.2.3.1. Tissue engineering
12.6.2.3.2. Transplantable organs
12.6.2.3.3. Drug development/screening
12.6.2.3.4. Toxicology Screening
12.6.2.3.5. Tissue model for cancer research
12.6.2.3.6. Others
12.6.2.4. Canada 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By End Users
12.6.2.4.1. Pharmaceutical Companies
12.6.2.4.2. Research and Academic Institutions
12.6.2.4.3. Medical Device Manufacturers
12.6.2.4.4. Contract Research Organization
12.6.3. Mexico
12.6.3.1. Mexico 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Offering
12.6.3.1.1. Hardware
12.6.3.1.1.1. Bioprinters
12.6.3.1.1.2. Bioinks
12.6.3.1.2. Solutions
12.6.3.2. Mexico 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Technology
12.6.3.2.1. Extrusion based
12.6.3.2.2. Ink-jet
12.6.3.2.3. Laser based
12.6.3.2.4. Press-assisted
12.6.3.2.5. Stereolithography
12.6.3.2.6. Light based
12.6.3.2.7. Others
12.6.3.3. Mexico 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Application
12.6.3.3.1. Tissue engineering
12.6.3.3.2. Transplantable organs
12.6.3.3.3. Drug development/screening
12.6.3.3.4. Toxicology Screening
12.6.3.3.5. Tissue model for cancer research
12.6.3.3.6. Others
12.6.3.4. Mexico 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By End Users
12.6.3.4.1. Pharmaceutical Companies
12.6.3.4.2. Research and Academic Institutions
12.6.3.4.3. Medical Device Manufacturers
12.6.3.4.4. Contract Research Organization
12.6.4. Rest of
North America
12.6.4.1. Rest of North America 3D Bioprinting Market Revenue (US$ Mn)
and Forecasts, By Offering
12.6.4.1.1. Hardware
12.6.4.1.1.1. Bioprinters
12.6.4.1.1.2. Bioinks
12.6.4.1.2. Solutions
12.6.4.2. Rest of North America 3D Bioprinting Market Revenue (US$ Mn)
and Forecasts, By Technology
12.6.4.2.1. Extrusion based
12.6.4.2.2. Ink-jet
12.6.4.2.3. Laser based
12.6.4.2.4. Press-assisted
12.6.4.2.5. Stereolithography
12.6.4.2.6. Light based
12.6.4.2.7. Others
12.6.4.3. Rest of North America 3D Bioprinting Market Revenue (US$ Mn)
and Forecasts, By Application
12.6.4.3.1. Tissue engineering
12.6.4.3.2. Transplantable organs
12.6.4.3.3. Drug development/screening
12.6.4.3.4. Toxicology Screening
12.6.4.3.5. Tissue model for cancer research
12.6.4.3.6. Others
12.6.4.4. Rest of North America 3D Bioprinting Market Revenue (US$ Mn)
and Forecasts, By End Users
12.6.4.4.1. Pharmaceutical Companies
12.6.4.4.2. Research and Academic Institutions
12.6.4.4.3. Medical Device Manufacturers
12.6.4.4.4. Contract Research Organization
12.7. Key
Segment for Channeling Investments
12.7.1. By
Country
12.7.2. By
Offering
12.7.3. By
Technology
12.7.4. By
Application
12.7.5. By End Users
13. Europe 3D Bioprinting Market Analysis and Forecasts, 2022 -
2030
13.1. Overview
13.1.1. Europe
3D Bioprinting Market Revenue (US$ Mn)
13.2. Europe 3D
Bioprinting Market Revenue (US$ Mn) and Forecasts, By Offering
13.2.1. Hardware
13.2.1.1. Bioprinters
13.2.1.2. Bioinks
13.2.2. Solutions
13.3. Europe 3D
Bioprinting Market Revenue (US$ Mn) and Forecasts, By Technology
13.3.1. Extrusion
based
13.3.2. Ink-jet
13.3.3. Laser
based
13.3.4. Press-assisted
13.3.5. Stereolithography
13.3.6. Light
based
13.3.7. Others
13.4. Europe 3D
Bioprinting Market Revenue (US$ Mn) and Forecasts, By Application
13.4.1. Tissue
engineering
13.4.2. Transplantable
organs
13.4.3. Drug
development/screening
13.4.4. Toxicology
Screening
13.4.5. Tissue
model for cancer research
13.4.6. Others
13.5. Europe 3D
Bioprinting Market Revenue (US$ Mn) and Forecasts, By End Users
13.5.1. Pharmaceutical
Companies
13.5.2. Research
and Academic Institutions
13.5.3. Medical
Device Manufacturers
13.5.4. Contract
Research Organization
13.6. Europe 3D
Bioprinting Market Revenue (US$ Mn) and Forecasts, By Country
13.6.1. France
13.6.1.1. France 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Offering
13.6.1.1.1. Hardware
13.6.1.1.1.1. Bioprinters
13.6.1.1.1.2. Bioinks
13.6.1.1.2. Solutions
13.6.1.2. France 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Technology
13.6.1.2.1. Extrusion based
13.6.1.2.2. Ink-jet
13.6.1.2.3. Laser based
13.6.1.2.4. Press-assisted
13.6.1.2.5. Stereolithography
13.6.1.2.6. Light based
13.6.1.2.7. Others
13.6.1.3. France 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Application
13.6.1.3.1. Tissue engineering
13.6.1.3.2. Transplantable organs
13.6.1.3.3. Drug development/screening
13.6.1.3.4. Toxicology Screening
13.6.1.3.5. Tissue model for cancer research
13.6.1.3.6. Others
13.6.1.4. France 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.1.4.1. Pharmaceutical Companies
13.6.1.4.2. Research and Academic Institutions
13.6.1.4.3. Medical Device Manufacturers
13.6.1.4.4. Contract Research Organization
13.6.2. The UK
13.6.2.1. The UK 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Offering
13.6.2.1.1. Hardware
13.6.2.1.1.1. Bioprinters
13.6.2.1.1.2. Bioinks
13.6.2.1.2. Solutions
13.6.2.2. The UK 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Technology
13.6.2.2.1. Extrusion based
13.6.2.2.2. Ink-jet
13.6.2.2.3. Laser based
13.6.2.2.4. Press-assisted
13.6.2.2.5. Stereolithography
13.6.2.2.6. Light based
13.6.2.2.7. Others
13.6.2.3. The UK 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Application
13.6.2.3.1. Tissue engineering
13.6.2.3.2. Transplantable organs
13.6.2.3.3. Drug development/screening
13.6.2.3.4. Toxicology Screening
13.6.2.3.5. Tissue model for cancer research
13.6.2.3.6. Others
13.6.2.4. The UK 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.2.4.1. Pharmaceutical Companies
13.6.2.4.2. Research and Academic Institutions
13.6.2.4.3. Medical Device Manufacturers
13.6.2.4.4. Contract Research Organization
13.6.3. Spain
13.6.3.1. Spain 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Offering
13.6.3.1.1. Hardware
13.6.3.1.1.1. Bioprinters
13.6.3.1.1.2. Bioinks
13.6.3.1.2. Solutions
13.6.3.2. Spain 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Technology
13.6.3.2.1. Extrusion based
13.6.3.2.2. Ink-jet
13.6.3.2.3. Laser based
13.6.3.2.4. Press-assisted
13.6.3.2.5. Stereolithography
13.6.3.2.6. Light based
13.6.3.2.7. Others
13.6.3.3. Spain 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Application
13.6.3.3.1. Tissue engineering
13.6.3.3.2. Transplantable organs
13.6.3.3.3. Drug development/screening
13.6.3.3.4. Toxicology Screening
13.6.3.3.5. Tissue model for cancer research
13.6.3.3.6. Others
13.6.3.4. Spain 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.3.4.1. Pharmaceutical Companies
13.6.3.4.2. Research and Academic Institutions
13.6.3.4.3. Medical Device Manufacturers
13.6.3.4.4. Contract Research Organization
13.6.4. Germany
13.6.4.1. Germany 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Offering
13.6.4.1.1. Hardware
13.6.4.1.1.1. Bioprinters
13.6.4.1.1.2. Bioinks
13.6.4.1.2. Solutions
13.6.4.2. Germany 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Technology
13.6.4.2.1. Extrusion based
13.6.4.2.2. Ink-jet
13.6.4.2.3. Laser based
13.6.4.2.4. Press-assisted
13.6.4.2.5. Stereolithography
13.6.4.2.6. Light based
13.6.4.2.7. Others
13.6.4.3. Germany 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Application
13.6.4.3.1. Tissue engineering
13.6.4.3.2. Transplantable organs
13.6.4.3.3. Drug development/screening
13.6.4.3.4. Toxicology Screening
13.6.4.3.5. Tissue model for cancer research
13.6.4.3.6. Others
13.6.4.4. Germany 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.4.4.1. Pharmaceutical Companies
13.6.4.4.2. Research and Academic Institutions
13.6.4.4.3. Medical Device Manufacturers
13.6.4.4.4. Contract Research Organization
13.6.5. Italy
13.6.5.1. Italy 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Offering
13.6.5.1.1. Hardware
13.6.5.1.1.1. Bioprinters
13.6.5.1.1.2. Bioinks
13.6.5.1.2. Solutions
13.6.5.2. Italy 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Technology
13.6.5.2.1. Extrusion based
13.6.5.2.2. Ink-jet
13.6.5.2.3. Laser based
13.6.5.2.4. Press-assisted
13.6.5.2.5. Stereolithography
13.6.5.2.6. Light based
13.6.5.2.7. Others
13.6.5.3. Italy 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Application
13.6.5.3.1. Tissue engineering
13.6.5.3.2. Transplantable organs
13.6.5.3.3. Drug development/screening
13.6.5.3.4. Toxicology Screening
13.6.5.3.5. Tissue model for cancer research
13.6.5.3.6. Others
13.6.5.4. Italy 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By End Users
13.6.5.4.1. Pharmaceutical Companies
13.6.5.4.2. Research and Academic Institutions
13.6.5.4.3. Medical Device Manufacturers
13.6.5.4.4. Contract Research Organization
13.6.6. Nordic
Countries
13.6.6.1. Nordic Countries 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Offering
13.6.6.1.1. Hardware
13.6.6.1.1.1. Bioprinters
13.6.6.1.1.2. Bioinks
13.6.6.1.2. Solutions
13.6.6.2. Nordic Countries 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Technology
13.6.6.2.1. Extrusion based
13.6.6.2.2. Ink-jet
13.6.6.2.3. Laser based
13.6.6.2.4. Press-assisted
13.6.6.2.5. Stereolithography
13.6.6.2.6. Light based
13.6.6.2.7. Others
13.6.6.3. Nordic Countries 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.6.3.1. Tissue engineering
13.6.6.3.2. Transplantable organs
13.6.6.3.3. Drug development/screening
13.6.6.3.4. Toxicology Screening
13.6.6.3.5. Tissue model for cancer research
13.6.6.3.6. Others
13.6.6.4. Nordic Countries 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.6.4.1. Pharmaceutical Companies
13.6.6.4.2. Research and Academic Institutions
13.6.6.4.3. Medical Device Manufacturers
13.6.6.4.4. Contract Research Organization
13.6.6.5. Nordic Countries 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.6.5.1. Denmark
13.6.6.5.2. Finland
13.6.6.5.3. Iceland
13.6.6.5.4. Sweden
13.6.6.5.5. Norway
13.6.7. Benelux
Union
13.6.7.1. Benelux Union 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Offering
13.6.7.1.1. Hardware
13.6.7.1.1.1. Bioprinters
13.6.7.1.1.2. Bioinks
13.6.7.1.2. Solutions
13.6.7.2. Benelux Union 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Technology
13.6.7.2.1. Extrusion based
13.6.7.2.2. Ink-jet
13.6.7.2.3. Laser based
13.6.7.2.4. Press-assisted
13.6.7.2.5. Stereolithography
13.6.7.2.6. Light based
13.6.7.2.7. Others
13.6.7.3. Benelux Union 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.7.3.1. Tissue engineering
13.6.7.3.2. Transplantable organs
13.6.7.3.3. Drug development/screening
13.6.7.3.4. Toxicology Screening
13.6.7.3.5. Tissue model for cancer research
13.6.7.3.6. Others
13.6.7.4. Benelux Union 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.7.4.1. Pharmaceutical Companies
13.6.7.4.2. Research and Academic Institutions
13.6.7.4.3. Medical Device Manufacturers
13.6.7.4.4. Contract Research Organization
13.6.7.5. Benelux Union 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.7.5.1. Belgium
13.6.7.5.2. The Netherlands
13.6.7.5.3. Luxembourg
13.6.8. Rest of
Europe
13.6.8.1. Rest of Europe 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Offering
13.6.8.1.1. Hardware
13.6.8.1.1.1. Bioprinters
13.6.8.1.1.2. Bioinks
13.6.8.1.2. Solutions
13.6.8.2. Rest of Europe 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Technology
13.6.8.2.1. Extrusion based
13.6.8.2.2. Ink-jet
13.6.8.2.3. Laser based
13.6.8.2.4. Press-assisted
13.6.8.2.5. Stereolithography
13.6.8.2.6. Light based
13.6.8.2.7. Others
13.6.8.3. Rest of Europe 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Application
13.6.8.3.1. Tissue engineering
13.6.8.3.2. Transplantable organs
13.6.8.3.3. Drug development/screening
13.6.8.3.4. Toxicology Screening
13.6.8.3.5. Tissue model for cancer research
13.6.8.3.6. Others
13.6.8.4. Rest of Europe 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By End Users
13.6.8.4.1. Pharmaceutical Companies
13.6.8.4.2. Research and Academic Institutions
13.6.8.4.3. Medical Device Manufacturers
13.6.8.4.4. Contract Research Organization
13.7. Key
Segment for Channeling Investments
13.7.1. By Country
13.7.2. By
Offering
13.7.3. By
Technology
13.7.4. By
Application
13.7.5. By End Users
14. Asia Pacific 3D Bioprinting Market Analysis and Forecasts, 2022
- 2030
14.1. Overview
14.1.1. Asia
Pacific 3D Bioprinting Market Revenue (US$ Mn)
14.2. Asia
Pacific 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By Offering
14.2.1. Hardware
14.2.1.1. Bioprinters
14.2.1.2. Bioinks
14.2.2. Solutions
14.3. Asia
Pacific 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By Technology
14.3.1. Extrusion
based
14.3.2. Ink-jet
14.3.3. Laser
based
14.3.4. Press-assisted
14.3.5. Stereolithography
14.3.6. Light
based
14.3.7. Others
14.4. Asia Pacific
3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By Application
14.4.1. Tissue
engineering
14.4.2. Transplantable
organs
14.4.3. Drug
development/screening
14.4.4. Toxicology
Screening
14.4.5. Tissue
model for cancer research
14.4.6. Others
14.5. Asia
Pacific 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.1. Pharmaceutical
Companies
14.5.2. Research
and Academic Institutions
14.5.3. Medical
Device Manufacturers
14.5.4. Contract
Research Organization
14.6. Asia
Pacific 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By Country
14.6.1. China
14.6.1.1. China 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Offering
14.6.1.1.1. Hardware
14.6.1.1.1.1. Bioprinters
14.6.1.1.1.2. Bioinks
14.6.1.1.2. Solutions
14.6.1.2. China 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Technology
14.6.1.2.1. Extrusion based
14.6.1.2.2. Ink-jet
14.6.1.2.3. Laser based
14.6.1.2.4. Press-assisted
14.6.1.2.5. Stereolithography
14.6.1.2.6. Light based
14.6.1.2.7. Others
14.6.1.3. China 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Application
14.6.1.3.1. Tissue engineering
14.6.1.3.2. Transplantable organs
14.6.1.3.3. Drug development/screening
14.6.1.3.4. Toxicology Screening
14.6.1.3.5. Tissue model for cancer research
14.6.1.3.6. Others
14.6.1.4. China 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By End Users
14.6.1.4.1. Pharmaceutical Companies
14.6.1.4.2. Research and Academic Institutions
14.6.1.4.3. Medical Device Manufacturers
14.6.1.4.4. Contract Research Organization
14.6.2. Japan
14.6.2.1. Japan 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Offering
14.6.2.1.1. Hardware
14.6.2.1.1.1. Bioprinters
14.6.2.1.1.2. Bioinks
14.6.2.1.2. Solutions
14.6.2.2. Japan 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Technology
14.6.2.2.1. Extrusion based
14.6.2.2.2. Ink-jet
14.6.2.2.3. Laser based
14.6.2.2.4. Press-assisted
14.6.2.2.5. Stereolithography
14.6.2.2.6. Light based
14.6.2.2.7. Others
14.6.2.3. Japan 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Application
14.6.2.3.1. Tissue engineering
14.6.2.3.2. Transplantable organs
14.6.2.3.3. Drug development/screening
14.6.2.3.4. Toxicology Screening
14.6.2.3.5. Tissue model for cancer research
14.6.2.3.6. Others
14.6.2.4. Japan 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By End Users
14.6.2.4.1. Pharmaceutical Companies
14.6.2.4.2. Research and Academic Institutions
14.6.2.4.3. Medical Device Manufacturers
14.6.2.4.4. Contract Research Organization
14.6.3. India
14.6.3.1. India 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Offering
14.6.3.1.1. Hardware
14.6.3.1.1.1. Bioprinters
14.6.3.1.1.2. Bioinks
14.6.3.1.2. Solutions
14.6.3.2. India 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Technology
14.6.3.2.1. Extrusion based
14.6.3.2.2. Ink-jet
14.6.3.2.3. Laser based
14.6.3.2.4. Press-assisted
14.6.3.2.5. Stereolithography
14.6.3.2.6. Light based
14.6.3.2.7. Others
14.6.3.3. India 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Application
14.6.3.3.1. Tissue engineering
14.6.3.3.2. Transplantable organs
14.6.3.3.3. Drug development/screening
14.6.3.3.4. Toxicology Screening
14.6.3.3.5. Tissue model for cancer research
14.6.3.3.6. Others
14.6.3.4. India 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By End Users
14.6.3.4.1. Pharmaceutical Companies
14.6.3.4.2. Research and Academic Institutions
14.6.3.4.3. Medical Device Manufacturers
14.6.3.4.4. Contract Research Organization
14.6.4. New
Zealand
14.6.4.1. New Zealand 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.4.1.1. Hardware
14.6.4.1.1.1. Bioprinters
14.6.4.1.1.2. Bioinks
14.6.4.1.2. Solutions
14.6.4.2. New Zealand 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Technology
14.6.4.2.1. Extrusion based
14.6.4.2.2. Ink-jet
14.6.4.2.3. Laser based
14.6.4.2.4. Press-assisted
14.6.4.2.5. Stereolithography
14.6.4.2.6. Light based
14.6.4.2.7. Others
14.6.4.3. New Zealand 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.4.3.1. Tissue engineering
14.6.4.3.2. Transplantable organs
14.6.4.3.3. Drug development/screening
14.6.4.3.4. Toxicology Screening
14.6.4.3.5. Tissue model for cancer research
14.6.4.3.6. Others
14.6.4.4. New Zealand 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.4.4.1. Pharmaceutical Companies
14.6.4.4.2. Research and Academic Institutions
14.6.4.4.3. Medical Device Manufacturers
14.6.4.4.4. Contract Research Organization
14.6.5. Australia
14.6.5.1. Australia 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.5.1.1. Hardware
14.6.5.1.1.1. Bioprinters
14.6.5.1.1.2. Bioinks
14.6.5.1.2. Solutions
14.6.5.2. Australia 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Technology
14.6.5.2.1. Extrusion based
14.6.5.2.2. Ink-jet
14.6.5.2.3. Laser based
14.6.5.2.4. Press-assisted
14.6.5.2.5. Stereolithography
14.6.5.2.6. Light based
14.6.5.2.7. Others
14.6.5.3. Australia 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.5.3.1. Tissue engineering
14.6.5.3.2. Transplantable organs
14.6.5.3.3. Drug development/screening
14.6.5.3.4. Toxicology Screening
14.6.5.3.5. Tissue model for cancer research
14.6.5.3.6. Others
14.6.5.4. Australia 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.5.4.1. Pharmaceutical Companies
14.6.5.4.2. Research and Academic Institutions
14.6.5.4.3. Medical Device Manufacturers
14.6.5.4.4. Contract Research Organization
14.6.6. South
Korea
14.6.6.1. South Korea 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.6.1.1. Hardware
14.6.6.1.1.1. Bioprinters
14.6.6.1.1.2. Bioinks
14.6.6.1.2. Solutions
14.6.6.2. South Korea 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Technology
14.6.6.2.1. Extrusion based
14.6.6.2.2. Ink-jet
14.6.6.2.3. Laser based
14.6.6.2.4. Press-assisted
14.6.6.2.5. Stereolithography
14.6.6.2.6. Light based
14.6.6.2.7. Others
14.6.6.3. South Korea 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.6.3.1. Tissue engineering
14.6.6.3.2. Transplantable organs
14.6.6.3.3. Drug development/screening
14.6.6.3.4. Toxicology Screening
14.6.6.3.5. Tissue model for cancer research
14.6.6.3.6. Others
14.6.6.4. South Korea 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.6.4.1. Pharmaceutical Companies
14.6.6.4.2. Research and Academic Institutions
14.6.6.4.3. Medical Device Manufacturers
14.6.6.4.4. Contract Research Organization
14.6.7. Southeast
Asia
14.6.7.1. Southeast Asia 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.7.1.1. Hardware
14.6.7.1.1.1. Bioprinters
14.6.7.1.1.2. Bioinks
14.6.7.1.2. Solutions
14.6.7.2. Southeast Asia 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Technology
14.6.7.2.1. Extrusion based
14.6.7.2.2. Ink-jet
14.6.7.2.3. Laser based
14.6.7.2.4. Press-assisted
14.6.7.2.5. Stereolithography
14.6.7.2.6. Light based
14.6.7.2.7. Others
14.6.7.3. Southeast Asia 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Application
14.6.7.3.1. Tissue engineering
14.6.7.3.2. Transplantable organs
14.6.7.3.3. Drug development/screening
14.6.7.3.4. Toxicology Screening
14.6.7.3.5. Tissue model for cancer research
14.6.7.3.6. Others
14.6.7.4. Southeast Asia 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By End Users
14.6.7.4.1. Pharmaceutical Companies
14.6.7.4.2. Research and Academic Institutions
14.6.7.4.3. Medical Device Manufacturers
14.6.7.4.4. Contract Research Organization
14.6.7.5. Southeast Asia 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Country
14.6.7.5.1. Indonesia
14.6.7.5.2. Thailand
14.6.7.5.3. Malaysia
14.6.7.5.4. Singapore
14.6.7.5.5. Rest of Southeast Asia
14.6.8. Rest of
Asia Pacific
14.6.8.1. Rest of Asia Pacific 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Offering
14.6.8.1.1. Hardware
14.6.8.1.1.1. Bioprinters
14.6.8.1.1.2. Bioinks
14.6.8.1.2. Solutions
14.6.8.2. Rest of Asia Pacific 3D Bioprinting Market Revenue (US$ Mn)
and Forecasts, By Technology
14.6.8.2.1. Extrusion based
14.6.8.2.2. Ink-jet
14.6.8.2.3. Laser based
14.6.8.2.4. Press-assisted
14.6.8.2.5. Stereolithography
14.6.8.2.6. Light based
14.6.8.2.7. Others
14.6.8.3. Rest of Asia Pacific 3D Bioprinting Market Revenue (US$ Mn)
and Forecasts, By Application
14.6.8.3.1. Tissue engineering
14.6.8.3.2. Transplantable organs
14.6.8.3.3. Drug development/screening
14.6.8.3.4. Toxicology Screening
14.6.8.3.5. Tissue model for cancer research
14.6.8.3.6. Others
14.6.8.4. Rest of Asia Pacific 3D Bioprinting Market Revenue (US$ Mn)
and Forecasts, By End Users
14.6.8.4.1. Pharmaceutical Companies
14.6.8.4.2. Research and Academic Institutions
14.6.8.4.3. Medical Device Manufacturers
14.6.8.4.4. Contract Research Organization
14.7. Key
Segment for Channeling Investments
14.7.1. By Country
14.7.2. By
Offering
14.7.3. By
Technology
14.7.4. By
Application
14.7.5. By End Users
15. Middle East and Africa 3D Bioprinting Market Analysis and
Forecasts, 2022 - 2030
15.1. Overview
15.1.1. Middle
East and Africa 3D Bioprinting Market Revenue (US$ Mn)
15.2. Middle
East and Africa 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Offering
15.2.1. Hardware
15.2.1.1. Bioprinters
15.2.1.2. Bioinks
15.2.2. Solutions
15.3. Middle
East and Africa 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Technology
15.3.1. Extrusion
based
15.3.2. Ink-jet
15.3.3. Laser
based
15.3.4. Press-assisted
15.3.5. Stereolithography
15.3.6. Light
based
15.3.7. Others
15.4. Middle
East and Africa 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Application
15.4.1. Tissue
engineering
15.4.2. Transplantable
organs
15.4.3. Drug
development/screening
15.4.4. Toxicology
Screening
15.4.5. Tissue
model for cancer research
15.4.6. Others
15.5. Middle
East and Africa 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By End Users
15.5.1. Pharmaceutical
Companies
15.5.2. Research
and Academic Institutions
15.5.3. Medical
Device Manufacturers
15.5.4. Contract
Research Organization
15.6. Middle
East and Africa 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Country
15.6.1. Saudi
Arabia
15.6.1.1. Saudi Arabia 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Offering
15.6.1.1.1. Hardware
15.6.1.1.1.1. Bioprinters
15.6.1.1.1.2. Bioinks
15.6.1.1.2. Solutions
15.6.1.2. Saudi Arabia 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Technology
15.6.1.2.1. Extrusion based
15.6.1.2.2. Ink-jet
15.6.1.2.3. Laser based
15.6.1.2.4. Press-assisted
15.6.1.2.5. Stereolithography
15.6.1.2.6. Light based
15.6.1.2.7. Others
15.6.1.3. Saudi Arabia 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.1.3.1. Tissue engineering
15.6.1.3.2. Transplantable organs
15.6.1.3.3. Drug development/screening
15.6.1.3.4. Toxicology Screening
15.6.1.3.5. Tissue model for cancer research
15.6.1.3.6. Others
15.6.1.4. Saudi Arabia 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.1.4.1. Pharmaceutical Companies
15.6.1.4.2. Research and Academic Institutions
15.6.1.4.3. Medical Device Manufacturers
15.6.1.4.4. Contract Research Organization
15.6.2. UAE
15.6.2.1. UAE 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Offering
15.6.2.1.1. Hardware
15.6.2.1.1.1. Bioprinters
15.6.2.1.1.2. Bioinks
15.6.2.1.2. Solutions
15.6.2.2. UAE 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Technology
15.6.2.2.1. Extrusion based
15.6.2.2.2. Ink-jet
15.6.2.2.3. Laser based
15.6.2.2.4. Press-assisted
15.6.2.2.5. Stereolithography
15.6.2.2.6. Light based
15.6.2.2.7. Others
15.6.2.3. UAE 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Application
15.6.2.3.1. Tissue engineering
15.6.2.3.2. Transplantable organs
15.6.2.3.3. Drug development/screening
15.6.2.3.4. Toxicology Screening
15.6.2.3.5. Tissue model for cancer research
15.6.2.3.6. Others
15.6.2.4. UAE 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By End Users
15.6.2.4.1. Pharmaceutical Companies
15.6.2.4.2. Research and Academic Institutions
15.6.2.4.3. Medical Device Manufacturers
15.6.2.4.4. Contract Research Organization
15.6.3. Egypt
15.6.3.1. Egypt 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Offering
15.6.3.1.1. Hardware
15.6.3.1.1.1. Bioprinters
15.6.3.1.1.2. Bioinks
15.6.3.1.2. Solutions
15.6.3.2. Egypt 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Technology
15.6.3.2.1. Extrusion based
15.6.3.2.2. Ink-jet
15.6.3.2.3. Laser based
15.6.3.2.4. Press-assisted
15.6.3.2.5. Stereolithography
15.6.3.2.6. Light based
15.6.3.2.7. Others
15.6.3.3. Egypt 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By
Application
15.6.3.3.1. Tissue engineering
15.6.3.3.2. Transplantable organs
15.6.3.3.3. Drug development/screening
15.6.3.3.4. Toxicology Screening
15.6.3.3.5. Tissue model for cancer research
15.6.3.3.6. Others
15.6.3.4. Egypt 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By End Users
15.6.3.4.1. Pharmaceutical Companies
15.6.3.4.2. Research and Academic Institutions
15.6.3.4.3. Medical Device Manufacturers
15.6.3.4.4. Contract Research Organization
15.6.4. Kuwait
15.6.4.1. Kuwait 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Offering
15.6.4.1.1. Hardware
15.6.4.1.1.1. Bioprinters
15.6.4.1.1.2. Bioinks
15.6.4.1.2. Solutions
15.6.4.2. Kuwait 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Technology
15.6.4.2.1. Extrusion based
15.6.4.2.2. Ink-jet
15.6.4.2.3. Laser based
15.6.4.2.4. Press-assisted
15.6.4.2.5. Stereolithography
15.6.4.2.6. Light based
15.6.4.2.7. Others
15.6.4.3. Kuwait 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Application
15.6.4.3.1. Tissue engineering
15.6.4.3.2. Transplantable organs
15.6.4.3.3. Drug development/screening
15.6.4.3.4. Toxicology Screening
15.6.4.3.5. Tissue model for cancer research
15.6.4.3.6. Others
15.6.4.4. Kuwait 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By End Users
15.6.4.4.1. Pharmaceutical Companies
15.6.4.4.2. Research and Academic Institutions
15.6.4.4.3. Medical Device Manufacturers
15.6.4.4.4. Contract Research Organization
15.6.5. South
Africa
15.6.5.1. South Africa 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Offering
15.6.5.1.1. Hardware
15.6.5.1.1.1. Bioprinters
15.6.5.1.1.2. Bioinks
15.6.5.1.2. Solutions
15.6.5.2. South Africa 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Technology
15.6.5.2.1. Extrusion based
15.6.5.2.2. Ink-jet
15.6.5.2.3. Laser based
15.6.5.2.4. Press-assisted
15.6.5.2.5. Stereolithography
15.6.5.2.6. Light based
15.6.5.2.7. Others
15.6.5.3. South Africa 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Application
15.6.5.3.1. Tissue engineering
15.6.5.3.2. Transplantable organs
15.6.5.3.3. Drug development/screening
15.6.5.3.4. Toxicology Screening
15.6.5.3.5. Tissue model for cancer research
15.6.5.3.6. Others
15.6.5.4. South Africa 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By End Users
15.6.5.4.1. Pharmaceutical Companies
15.6.5.4.2. Research and Academic Institutions
15.6.5.4.3. Medical Device Manufacturers
15.6.5.4.4. Contract Research Organization
15.6.6. Rest of
Middle East & Africa
15.6.6.1. Rest of Middle East & Africa 3D Bioprinting Market Revenue
(US$ Mn) and Forecasts, By Offering
15.6.6.1.1. Hardware
15.6.6.1.1.1. Bioprinters
15.6.6.1.1.2. Bioinks
15.6.6.1.2. Solutions
15.6.6.2. Rest of Middle East & Africa 3D Bioprinting Market Revenue
(US$ Mn) and Forecasts, By Technology
15.6.6.2.1. Extrusion based
15.6.6.2.2. Ink-jet
15.6.6.2.3. Laser based
15.6.6.2.4. Press-assisted
15.6.6.2.5. Stereolithography
15.6.6.2.6. Light based
15.6.6.2.7. Others
15.6.6.3. Rest of Middle East & Africa 3D Bioprinting Market Revenue
(US$ Mn) and Forecasts, By Application
15.6.6.3.1. Tissue engineering
15.6.6.3.2. Transplantable organs
15.6.6.3.3. Drug development/screening
15.6.6.3.4. Toxicology Screening
15.6.6.3.5. Tissue model for cancer research
15.6.6.3.6. Others
15.6.6.4. Rest of Middle East & Africa 3D Bioprinting Market Revenue
(US$ Mn) and Forecasts, By End Users
15.6.6.4.1. Pharmaceutical Companies
15.6.6.4.2. Research and Academic Institutions
15.6.6.4.3. Medical Device Manufacturers
15.6.6.4.4. Contract Research Organization
15.7. Key
Segment for Channeling Investments
15.7.1. By
Country
15.7.2. By
Offering
15.7.3. By
Technology
15.7.4. By
Application
15.7.5. By End Users
16. Latin America 3D Bioprinting Market Analysis and Forecasts, 2022
- 2030
16.1. Overview
16.1.1. Latin
America 3D Bioprinting Market Revenue (US$ Mn)
16.2. Latin
America 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By Offering
16.2.1. Hardware
16.2.1.1. Bioprinters
16.2.1.2. Bioinks
16.2.2. Solutions
16.3. Latin
America 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By Technology
16.3.1. Extrusion
based
16.3.2. Ink-jet
16.3.3. Laser
based
16.3.4. Press-assisted
16.3.5. Stereolithography
16.3.6. Light
based
16.3.7. Others
16.4. Latin
America 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By Application
16.4.1. Tissue
engineering
16.4.2. Transplantable
organs
16.4.3. Drug
development/screening
16.4.4. Toxicology
Screening
16.4.5. Tissue
model for cancer research
16.4.6. Others
16.5. Latin
America 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By End Users
16.5.1. Pharmaceutical
Companies
16.5.2. Research
and Academic Institutions
16.5.3. Medical
Device Manufacturers
16.5.4. Contract
Research Organization
16.6. Latin
America 3D Bioprinting Market Revenue (US$ Mn) and Forecasts, By Country
16.6.1. Brazil
16.6.1.1. Brazil 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Offering
16.6.1.1.1. Hardware
16.6.1.1.1.1. Bioprinters
16.6.1.1.1.2. Bioinks
16.6.1.1.2. Solutions
16.6.1.2. Brazil 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Technology
16.6.1.2.1. Extrusion based
16.6.1.2.2. Ink-jet
16.6.1.2.3. Laser based
16.6.1.2.4. Press-assisted
16.6.1.2.5. Stereolithography
16.6.1.2.6. Light based
16.6.1.2.7. Others
16.6.1.3. Brazil 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By Application
16.6.1.3.1. Tissue engineering
16.6.1.3.2. Transplantable organs
16.6.1.3.3. Drug development/screening
16.6.1.3.4. Toxicology Screening
16.6.1.3.5. Tissue model for cancer research
16.6.1.3.6. Others
16.6.1.4. Brazil 3D Bioprinting Market Revenue (US$ Mn) and Forecasts,
By End Users
16.6.1.4.1. Pharmaceutical Companies
16.6.1.4.2. Research and Academic Institutions
16.6.1.4.3. Medical Device Manufacturers
16.6.1.4.4. Contract Research Organization
16.6.2. Argentina
16.6.2.1. Argentina 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Offering
16.6.2.1.1. Hardware
16.6.2.1.1.1. Bioprinters
16.6.2.1.1.2. Bioinks
16.6.2.1.2. Solutions
16.6.2.2. Argentina 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Technology
16.6.2.2.1. Extrusion based
16.6.2.2.2. Ink-jet
16.6.2.2.3. Laser based
16.6.2.2.4. Press-assisted
16.6.2.2.5. Stereolithography
16.6.2.2.6. Light based
16.6.2.2.7. Others
16.6.2.3. Argentina 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By Application
16.6.2.3.1. Tissue engineering
16.6.2.3.2. Transplantable organs
16.6.2.3.3. Drug development/screening
16.6.2.3.4. Toxicology Screening
16.6.2.3.5. Tissue model for cancer research
16.6.2.3.6. Others
16.6.2.4. Argentina 3D Bioprinting Market Revenue (US$ Mn) and
Forecasts, By End Users
16.6.2.4.1. Pharmaceutical Companies
16.6.2.4.2. Research and Academic Institutions
16.6.2.4.3. Medical Device Manufacturers
16.6.2.4.4. Contract Research Organization
16.6.3. Rest of
Latin America
16.6.3.1. Rest of Latin America 3D Bioprinting Market Revenue (US$ Mn)
and Forecasts, By Offering
16.6.3.1.1. Hardware
16.6.3.1.1.1. Bioprinters
16.6.3.1.1.2. Bioinks
16.6.3.1.2. Solutions
16.6.3.2. Rest of Latin America 3D Bioprinting Market Revenue (US$ Mn)
and Forecasts, By Technology
16.6.3.2.1. Extrusion based
16.6.3.2.2. Ink-jet
16.6.3.2.3. Laser based
16.6.3.2.4. Press-assisted
16.6.3.2.5. Stereolithography
16.6.3.2.6. Light based
16.6.3.2.7. Others
16.6.3.3. Rest of Latin America 3D Bioprinting Market Revenue (US$ Mn)
and Forecasts, By Application
16.6.3.3.1. Tissue engineering
16.6.3.3.2. Transplantable organs
16.6.3.3.3. Drug development/screening
16.6.3.3.4. Toxicology Screening
16.6.3.3.5. Tissue model for cancer research
16.6.3.3.6. Others
16.6.3.4. Rest of Latin America 3D Bioprinting Market Revenue (US$ Mn)
and Forecasts, By End Users
16.6.3.4.1. Pharmaceutical Companies
16.6.3.4.2. Research and Academic Institutions
16.6.3.4.3. Medical Device Manufacturers
16.6.3.4.4. Contract Research Organization
16.7. Key
Segment for Channeling Investments
16.7.1. By
Country
16.7.2. By
Offering
16.7.3. By
Technology
16.7.4. By
Application
16.7.5. By End Users
17. Competitive Benchmarking
17.1. Brand Benchmarking
17.2. Market
Share Analysis, 2021
17.3. Global
Presence and Growth Strategies
17.3.1. Mergers
and Acquisitions
17.3.2. Product
Launches
17.3.3. Investments
Trends
17.3.4. R&D
Initiatives
18. Player Profiles
18.1. 3D
Systems, Inc
18.1.1. Company
Details
18.1.2. Company
Overview
18.1.3. Product
Offerings
18.1.4. Key Developments
18.1.5. Financial
Analysis
18.1.6. SWOT
Analysis
18.1.7. Business
Strategies
18.2. Advanced
Solutions Life Sciences, LLC
18.2.1. Company
Details
18.2.2. Company
Overview
18.2.3. Product
Offerings
18.2.4. Key
Developments
18.2.5. Financial
Analysis
18.2.6. SWOT
Analysis
18.2.7. Business
Strategies
18.3. Allevi,
Inc.
18.3.1. Company
Details
18.3.2. Company
Overview
18.3.3. Product
Offerings
18.3.4. Key
Developments
18.3.5. Financial
Analysis
18.3.6. SWOT
Analysis
18.3.7. Business
Strategies
18.4. Aspect
Biosystems Ltd.
18.4.1. Company
Details
18.4.2. Company
Overview
18.4.3. Product
Offerings
18.4.4. Key
Developments
18.4.5. Financial
Analysis
18.4.6. SWOT
Analysis
18.4.7. Business
Strategies
18.5. Brinter
18.5.1. Company
Details
18.5.2. Company
Overview
18.5.3. Product
Offerings
18.5.4. Key
Developments
18.5.5. Financial
Analysis
18.5.6. SWOT
Analysis
18.5.7. Business
Strategies
18.6. Cellbricks
18.6.1. Company
Details
18.6.2. Company
Overview
18.6.3. Product
Offerings
18.6.4. Key
Developments
18.6.5. Financial
Analysis
18.6.6. SWOT
Analysis
18.6.7. Business
Strategies
18.7. CELLINK
18.7.1. Company
Details
18.7.2. Company
Overview
18.7.3. Product
Offerings
18.7.4. Key
Developments
18.7.5. Financial
Analysis
18.7.6. SWOT
Analysis
18.7.7. Business
Strategies
18.8. CYFUSE
BIOMEDICAL K.K.
18.8.1. Company
Details
18.8.2. Company
Overview
18.8.3. Product
Offerings
18.8.4. Key
Developments
18.8.5. Financial
Analysis
18.8.6. SWOT
Analysis
18.8.7. Business
Strategies
18.9. FELIXprinter
18.9.1. Company
Details
18.9.2. Company
Overview
18.9.3. Product
Offerings
18.9.4. Key
Developments
18.9.5. Financial
Analysis
18.9.6. SWOT
Analysis
18.9.7. Business
Strategies
18.10. Fluicell
AB
18.10.1. Company
Details
18.10.2. Company
Overview
18.10.3. Product
Offerings
18.10.4. Key Developments
18.10.5. Financial
Analysis
18.10.6. SWOT
Analysis
18.10.7. Business
Strategies
18.11. GeSim –
Gesellschaft für Silizium-Mikrosysteme mbH
18.11.1. Company
Details
18.11.2. Company
Overview
18.11.3. Product
Offerings
18.11.4. Key
Developments
18.11.5. Financial
Analysis
18.11.6. SWOT
Analysis
18.11.7. Business
Strategies
18.12. Medprin
18.12.1. Company
Details
18.12.2. Company
Overview
18.12.3. Product
Offerings
18.12.4. Key
Developments
18.12.5. Financial
Analysis
18.12.6. SWOT
Analysis
18.12.7. Business
Strategies
18.13. nScrypt
18.13.1. Company
Details
18.13.2. Company
Overview
18.13.3. Product
Offerings
18.13.4. Key
Developments
18.13.5. Financial
Analysis
18.13.6. SWOT
Analysis
18.13.7. Business
Strategies
18.14. Organovo
Holdings Inc
18.14.1. Company
Details
18.14.2. Company
Overview
18.14.3. Product
Offerings
18.14.4. Key
Developments
18.14.5. Financial
Analysis
18.14.6. SWOT
Analysis
18.14.7. Business
Strategies
18.15. regenHU
18.15.1. Company
Details
18.15.2. Company
Overview
18.15.3. Product
Offerings
18.15.4. Key
Developments
18.15.5. Financial
Analysis
18.15.6. SWOT
Analysis
18.15.7. Business Strategies
18.16. Other
Market Participants
19. Key Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
